SlideShare una empresa de Scribd logo
1 de 113
Molecular Perspectives In  Oncogenesis Marigold D.R. Majarucon-Ferrolino, MD , FPCP, FPSMO Department of Biochemistry & Nutrition  Our Lady of Fatima University College of Medicine
INTRODUCTION CANCER ,[object Object],[object Object]
CANCER CELLS AND NORMAL CELLS   CANCER CELLS NORMAL CELLS Loss of contact inhibition Increase in growth factor secretion Increase in oncogene expression Loss of tumor suppressor genes Oncogene expression is rare Intermittent or co-ordinated growth factor secretion Presence of tumor suppressor genes Normal cell Few mitoses Frequent mitoses Nucleus Blood vessel Abnormal heterogeneous cells
CHARACTERISTICS OF CANCER ,[object Object],[object Object],[object Object],[object Object]
CHARACTERISTICS OF CANCER Clonality ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cancer Genetics ,[object Object],[object Object],[object Object],[object Object],[object Object]
Evidence that Mutations Cause Cancer ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CHARACTERISTICS OF CANCER Autonomy
AUTONOMY ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Cell Cycle G1/S checkpoint G2/M checkpoint DEATH DIFFERENTIATION DNA  content  = 2n Mitosis M S DNA synthesis G 2   G 1 G 0 DNA  content  = 4n
CYCLIN, CDK,CDKI:  PHOSPHORYLATION
Cell Cycle Regulation ,[object Object],[object Object],[object Object]
G2/M Checkpoint ,[object Object],[object Object],[object Object],[object Object],[object Object]
G1/S Checkpoint ,[object Object],[object Object],[object Object],[object Object]
Rb Gene Activation
Cyclin Regulators ,[object Object],[object Object],[object Object]
Cyclin Regulators ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CHARACTERISTICS OF CANCER: Anaplasia ,[object Object],[object Object],[object Object],[object Object],[object Object]
Invasion and Metastasis ,[object Object],[object Object],[object Object]
ATTRIBUTES OF CANCER Metastasis ,[object Object],Destruction of the BM  Attachment to the laminin of distant BM ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Angiogenesis ,[object Object],[object Object],[object Object],[object Object]
INVASION AND METASTASIS
Triad of Invasion ,[object Object],[object Object],[object Object]
MOLECULAR CARCINOGENESIS Mutation ,[object Object],Gene Families in Cancer Development 1  - Oncogenes 2  - Tumor Suppressor genes 3  - Mutator genes
Cancer Genes ,[object Object],[object Object],[object Object]
ONCOGENE FAMILY  + oncogenes Oncogenes ,[object Object],[object Object],[object Object],cellular oncogenes [ c-oncs ]  Proto-oncogene    “Mutation”    Oncogene
ONCOGENE FAMILY  Classification of Oncogenes A.  Secreted Growth Factors B.  Cell Surface Receptors C.  Intracellular Transducers D.  DNA-binding Nuclear Proteins E.  Regulators of the Cell Cycle Components of signal transduction pathways c-sis, hst erb B, fms, ret, trk, fes, fms c-src, c-abl, mst, ras myc, jun, fos bcl, bax, bad
SIGNAL TRANSDUCTION
ONCOGENE FAMILY  Mechanisms of Oncogene Activation 1.  Point Mutation H-ras  [codon 12] Normal  C G C    Gly Bladder ca  C T C    Val H-ras GTP Perpetual cell division 2.  Gene Amplification Double minutes HSRs Normal copy Multiple copies
ONCOGENE FAMILY  Mechanisms of Oncogene Activation 3.  Gene Translocation Ex. Burkitt’s Lymphoma
ONCOGENE FAMILY  Mechanisms of Oncogene Activation 3.  Gene Translocation Ex. Chronic Myelogenous Leukemia [CML]
ONCOGENE FAMILY  Mechanisms of Oncogene Activation 4.  Viral Gene Integration promoter Viral promoter
TUMOR SUPPRESSOR GENE FAMILY  TS Genes ,[object Object],[object Object],[object Object],Classification of TS genes A. Cell Adhesion Molecules B. Regulators of the Cell Cycle APC, DCC RB1, Tp53
TUMOR SUPPRESSOR GENE FAMILY  KNUDSON’S Two-Hit Hypothesis 1st Hit : TS mutation or Inherited mutation 2nd Hit : gross chromosomal loss
TUMOR SUPPRESSOR GENE FAMILY  Retinoblastoma gene [ RB1  gene] ,[object Object],[object Object],pRb ,[object Object],[object Object],[object Object],viral oncoproteins [E1A, HPV E7]
TUMOR SUPPRESSOR GENE FAMILY  Tp53  gene ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TUMOR SUPPRESSOR GENE FAMILY  p53 protein
p53 in action
MUTATOR GENE FAMILY  Mutator Genes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
In summary …..  ONCOGENES TS GENES MUTATOR GENES
Re-cap of Molecular Carcinogenesis Proto-oncogene Gain-of-function TS gene Loss-of-function Mutator gene Loss-of-function CANCER
CARCINOGENS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Occupational Risk Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Lifestyle Risk Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diet-Related Risk Factors ,[object Object],[object Object],[object Object],[object Object],Gastric Cancer Esophageal Cancer
Diet-Related Risk Factors ,[object Object],[object Object],[object Object],[object Object],Colon Cancer Pancreatic Cancer Prostate Cancer Breast Cancer Uterine Cancer Mycotoxins Liver Cancer
Sexual Practices Risk Factors ,[object Object],Sexual promiscuity Multiple partners Unsafe Sex Human Papillomavirus
Multifactorial Factors ,[object Object],Oral Cavity Cancer Esophageal Cancer Tobacco + Asbestos Tobacco + mining Tobacco + uranium + radium Respiratory Tract Cancer Lung Cancer
CARCINOGEN METABOLISM Three Main Categories: I. Chemical Carcinogens II. Physical Carcinogens III. Viral Agents Carcinogens Mutations Cancer Environmental factors ?
CHEMICAL CARCINOGENESIS Stages: Initiation  - primary exposure Promotion  - transformation Progression  - Cancer growth Frank Cancer
CHEMICAL CARCINOGENESIS Initiation ,[object Object],[object Object],[object Object],[object Object],1. Direct-acting carcinogens 2. Indirect-acting carcinogens procarcinogen Cytochrome P450 Ultimate carcinogen
CHEMICAL CARCINOGENESIS Promotion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Types of Carcinogens …... 1. Direct carcinogens 2. Procarcinogens     Ultimate carcinogens
CHEMICAL CARCINOGENESIS Direct-acting Carcinogens ,[object Object],[object Object],[object Object],[object Object],Procarcinogens ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Promoters ,[object Object],[object Object],[object Object]
Physical Carcinogenesis ,[object Object],[object Object]
Sources of Potentially Carcinogenic Radiation ,[object Object],[object Object],[object Object],[object Object],[object Object]
PHYSICAL CARCINOGENESIS Ultraviolet Rays UV-A  = 320 - 400 nm UV-B  = 280 - 320 nm UV-C  = 200 - 280 nm
PHYSICAL CARCINOGENESIS Ultraviolet Rays UV-C     filtered by ozone UV-B Inhibition of cell division inactivation of enzymes induction of mutations cell death at high doses Squamous cell cancer Basal cell cancer Melanocarcinoma
PHYSICAL CARCINOGENESIS Ionizing Radiation ,[object Object],[object Object],[object Object],[object Object],PRE -IRRADIATION POST -IRRADIATION
Viral Carcinogenesis ,[object Object],[object Object]
Viral Oncogenes RETROVIRUS Oncogene Viral RNA Viral DNA NUCLEUS DNA Oncogene REVERSE TRANSCRIPTASE INSERTION TRANSCRIPTION Oncogene Viral RNA CELL MEMBRANE CYTOPLASM Viral genome RNA messenger TRANSCRIPTION Oncogene protein
Viruses Associated With The Development Of Human Neoplasia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Viruses Associated With The Development Of Human Neoplasia
VIRAL AGENTS:  DNA viruses Human Papillomavirus  [HPV types 16, 18, 31, 33 & 35] Interruption of the E1/E2 ORF E2 is not expressed Over-expression of E6 & E7
VIRAL AGENTS:  DNA viruses Epstein-Barr Virus [EBV] ,[object Object],[object Object],[object Object],Hepatitis B virus [HBV] ,[object Object],[object Object]
VIRAL AGENTS:  R NA viruses Human T-cell Leukemia Virus [HTLV] ,[object Object],[object Object],[object Object],Tax   protein    transcription    c-fos, c-sis, IL-1 and IL-2 Viral replication T cell proliferation
Principal Pathways of Malignancy   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SIGNAL TRANSDUCTION
PROLIFERATION (Growth Factor Signaling Pathway) ,[object Object],[object Object],[object Object],[object Object],[object Object]
PROLIFERATION (Growth Factor Signaling Pathway) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PROLIFERATION (Growth Factor Signaling Pathway) ,[object Object],[object Object],[object Object],[object Object]
PROLIFERATION
PROLIFERATION   (Growth Factor Signaling Pathway) ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Cell Cycle G1/S checkpoint G2/M checkpoint DEATH DIFFERENTIATION DNA  content  = 2n Mitosis M S DNA synthesis G 2   G 1 G 0 DNA  content  = 4n
Cell Cycle Regulation ,[object Object],[object Object],[object Object]
Cyclins and Cyclin-dependent Kinases (CDKs) ,[object Object],[object Object],[object Object],[object Object],[object Object]
G2/M Checkpoint ,[object Object],[object Object],[object Object],[object Object],[object Object]
CYCLIN, CDK,CDKI:  PHOSPHORYLATION
G1/S Checkpoint ,[object Object],[object Object],[object Object],[object Object],[object Object]
Rb Gene Activation
Cyclin Regulators- CDK Inhibitors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cyclin Regulators ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
p53 in action
CELL-CYCLE PROGRESSION
Clinical Significance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Therapeutic Implications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DNA REPAIR PATHWAYS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DNA REPAIR PATHWAYS ,[object Object],[object Object],[object Object],[object Object],[object Object]
IMMORTALIZATION
Telomeres and Telomerase ,[object Object],[object Object],[object Object],[object Object]
Telomeres and Telomerase ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
APOPTOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Apoptotic Pathway ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Apoptotic Pathway ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
APOPTOTIC PATHWAYS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Significance ,[object Object],[object Object],[object Object],[object Object],[object Object]
EVADING APOPTOSIS
Therapeutic Implications ,[object Object],[object Object],[object Object]
ANGIOGENESIS ,[object Object],[object Object],[object Object],[object Object]
Components of Angiogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Angiogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Angiogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Components of Angiogenesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANGIOGENESIS
Therapeutic Implications ,[object Object],[object Object],[object Object],[object Object],[object Object]
INVASION AND METASTASIS
Invasion and Metastasis ,[object Object],[object Object],[object Object]
PROCESS OF METASTASIS
Triad of Invasion ,[object Object],[object Object],[object Object]
ADHESION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
LOCAL PROTEOLYSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MOTILITY ,[object Object],[object Object],[object Object],[object Object],[object Object]
METASTASIS AND INVASION
THANK YOU !

Más contenido relacionado

La actualidad más candente (20)

Tumour supressor gene
Tumour supressor geneTumour supressor gene
Tumour supressor gene
 
Oncogenes
Oncogenes Oncogenes
Oncogenes
 
Molecular basis of Cancer
Molecular basis of CancerMolecular basis of Cancer
Molecular basis of Cancer
 
Proto oncogenes
Proto oncogenesProto oncogenes
Proto oncogenes
 
Cancer biology
Cancer biologyCancer biology
Cancer biology
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
 
Genetic basis of cancer
Genetic basis of cancerGenetic basis of cancer
Genetic basis of cancer
 
carcinogens and carcinogenesis
carcinogens and carcinogenesiscarcinogens and carcinogenesis
carcinogens and carcinogenesis
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor gene
 
biology of cancer
biology of cancerbiology of cancer
biology of cancer
 
Molecular biologyofca csbrp
Molecular biologyofca csbrpMolecular biologyofca csbrp
Molecular biologyofca csbrp
 
ONCOGENES
ONCOGENESONCOGENES
ONCOGENES
 
Carcinogen
CarcinogenCarcinogen
Carcinogen
 
Chapter 3 hallmarks of cancer
Chapter 3 hallmarks of cancerChapter 3 hallmarks of cancer
Chapter 3 hallmarks of cancer
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Viral oncogenesis
Viral oncogenesisViral oncogenesis
Viral oncogenesis
 
ONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENEONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENE
 
Oncogenes
Oncogenes Oncogenes
Oncogenes
 
Cancer Pathways
Cancer PathwaysCancer Pathways
Cancer Pathways
 
Molecular biology of cancer
Molecular biology of cancerMolecular biology of cancer
Molecular biology of cancer
 

Destacado

Destacado (15)

Oncogenesis
OncogenesisOncogenesis
Oncogenesis
 
CANCER
CANCERCANCER
CANCER
 
Echinocandins in the ICU
Echinocandins in the ICUEchinocandins in the ICU
Echinocandins in the ICU
 
Drug release kinetics
Drug release kineticsDrug release kinetics
Drug release kinetics
 
Cell death
Cell deathCell death
Cell death
 
Cell Adhesion and Cell Migration
Cell Adhesion and Cell MigrationCell Adhesion and Cell Migration
Cell Adhesion and Cell Migration
 
Oncogenes
Oncogenes Oncogenes
Oncogenes
 
Neoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancerNeoplasia Characteristics and classification of cancer
Neoplasia Characteristics and classification of cancer
 
Mitochondria ppt
Mitochondria pptMitochondria ppt
Mitochondria ppt
 
Oncogenes
OncogenesOncogenes
Oncogenes
 
Necrosis
NecrosisNecrosis
Necrosis
 
Apoptosis
ApoptosisApoptosis
Apoptosis
 
Apoptosis (presentation)
Apoptosis (presentation)Apoptosis (presentation)
Apoptosis (presentation)
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms
 
Controlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery SystemControlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery System
 

Similar a Oncogenesis

Mechanism of cancer 1-2.pptx
Mechanism of cancer 1-2.pptxMechanism of cancer 1-2.pptx
Mechanism of cancer 1-2.pptxNamita Potini
 
NEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESISNEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESISDr. Roopam Jain
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerRHMBONCO
 
molecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesismolecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesisUday Shanker Pandey
 
The Genetics of Cancer
The Genetics of CancerThe Genetics of Cancer
The Genetics of Cancermpattani
 
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssNORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssRashadHamada
 
Neoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseasesNeoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseasesFarazaJaved
 
Carcinogenesis.pptx
Carcinogenesis.pptxCarcinogenesis.pptx
Carcinogenesis.pptxMohd Azhan
 
Cancer Genetics - Denise Sheer
Cancer Genetics - Denise SheerCancer Genetics - Denise Sheer
Cancer Genetics - Denise SheerDenise Sheer
 
Molecular biology of oral cancer, ppt
Molecular biology of oral cancer, pptMolecular biology of oral cancer, ppt
Molecular biology of oral cancer, pptRaghda Ibrahim
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of CancerMohsin Shad
 
Oncology and characterization of malignant cells
Oncology and characterization of malignant cellsOncology and characterization of malignant cells
Oncology and characterization of malignant cellssfashaikh
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfMohitChauhan270470
 
Cancer by online teaching ot
Cancer by online teaching otCancer by online teaching ot
Cancer by online teaching otvidan biology
 
Molecular biology of cancer.pptx
Molecular biology of cancer.pptxMolecular biology of cancer.pptx
Molecular biology of cancer.pptxProsper Ingabire
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesisdrmcbansal
 

Similar a Oncogenesis (20)

Mechanism of cancer 1-2.pptx
Mechanism of cancer 1-2.pptxMechanism of cancer 1-2.pptx
Mechanism of cancer 1-2.pptx
 
NEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESISNEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESIS
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of Cancer
 
Cancer - Molecular basis
Cancer - Molecular basisCancer - Molecular basis
Cancer - Molecular basis
 
molecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesismolecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesis
 
The Genetics of Cancer
The Genetics of CancerThe Genetics of Cancer
The Genetics of Cancer
 
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssNORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
 
Microbiology:Tumor Suppressor Genes
Microbiology:Tumor Suppressor GenesMicrobiology:Tumor Suppressor Genes
Microbiology:Tumor Suppressor Genes
 
14 march seminar
14 march seminar14 march seminar
14 march seminar
 
Neoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseasesNeoplasia its Development Mechanisms and Neoplastic diseases
Neoplasia its Development Mechanisms and Neoplastic diseases
 
Carcinogenesis.pptx
Carcinogenesis.pptxCarcinogenesis.pptx
Carcinogenesis.pptx
 
Cancer Genetics - Denise Sheer
Cancer Genetics - Denise SheerCancer Genetics - Denise Sheer
Cancer Genetics - Denise Sheer
 
Molecular biology of oral cancer, ppt
Molecular biology of oral cancer, pptMolecular biology of oral cancer, ppt
Molecular biology of oral cancer, ppt
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of Cancer
 
Cancer
CancerCancer
Cancer
 
Oncology and characterization of malignant cells
Oncology and characterization of malignant cellsOncology and characterization of malignant cells
Oncology and characterization of malignant cells
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdf
 
Cancer by online teaching ot
Cancer by online teaching otCancer by online teaching ot
Cancer by online teaching ot
 
Molecular biology of cancer.pptx
Molecular biology of cancer.pptxMolecular biology of cancer.pptx
Molecular biology of cancer.pptx
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 

Más de MD Specialclass

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...MD Specialclass
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionMD Specialclass
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headachesMD Specialclass
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL MD Specialclass
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL MD Specialclass
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinomaMD Specialclass
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disordersMD Specialclass
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitisMD Specialclass
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosisMD Specialclass
 

Más de MD Specialclass (20)

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutrition
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headaches
 
Acute brain attack 911
Acute brain attack  911Acute brain attack  911
Acute brain attack 911
 
Hema intro anemia
Hema intro anemiaHema intro anemia
Hema intro anemia
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
Fever & id diet final
Fever & id diet finalFever & id diet final
Fever & id diet final
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disorders
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Thyroid
ThyroidThyroid
Thyroid
 
Dermatology dr.n.ramos
Dermatology   dr.n.ramosDermatology   dr.n.ramos
Dermatology dr.n.ramos
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitis
 
Pancreatic disease
Pancreatic diseasePancreatic disease
Pancreatic disease
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosis
 

Último

08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking MenDelhi Call girls
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilV3cube
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationRadu Cotescu
 
08448380779 Call Girls In Greater Kailash - I Women Seeking Men
08448380779 Call Girls In Greater Kailash - I Women Seeking Men08448380779 Call Girls In Greater Kailash - I Women Seeking Men
08448380779 Call Girls In Greater Kailash - I Women Seeking MenDelhi Call girls
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationSafe Software
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024The Digital Insurer
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreternaman860154
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking MenDelhi Call girls
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024The Digital Insurer
 
Factors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptxFactors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptxKatpro Technologies
 
Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Paola De la Torre
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Servicegiselly40
 
Handwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsHandwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsMaria Levchenko
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slidevu2urc
 
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdfThe Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdfEnterprise Knowledge
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024Results
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptxHampshireHUG
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Miguel Araújo
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘RTylerCroy
 

Último (20)

08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men08448380779 Call Girls In Civil Lines Women Seeking Men
08448380779 Call Girls In Civil Lines Women Seeking Men
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
08448380779 Call Girls In Greater Kailash - I Women Seeking Men
08448380779 Call Girls In Greater Kailash - I Women Seeking Men08448380779 Call Girls In Greater Kailash - I Women Seeking Men
08448380779 Call Girls In Greater Kailash - I Women Seeking Men
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
Presentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreterPresentation on how to chat with PDF using ChatGPT code interpreter
Presentation on how to chat with PDF using ChatGPT code interpreter
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
Factors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptxFactors to Consider When Choosing Accounts Payable Services Providers.pptx
Factors to Consider When Choosing Accounts Payable Services Providers.pptx
 
Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101Salesforce Community Group Quito, Salesforce 101
Salesforce Community Group Quito, Salesforce 101
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
 
Handwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsHandwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed texts
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slide
 
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdfThe Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024A Call to Action for Generative AI in 2024
A Call to Action for Generative AI in 2024
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 

Oncogenesis

  • 1. Molecular Perspectives In Oncogenesis Marigold D.R. Majarucon-Ferrolino, MD , FPCP, FPSMO Department of Biochemistry & Nutrition Our Lady of Fatima University College of Medicine
  • 2.
  • 3. CANCER CELLS AND NORMAL CELLS CANCER CELLS NORMAL CELLS Loss of contact inhibition Increase in growth factor secretion Increase in oncogene expression Loss of tumor suppressor genes Oncogene expression is rare Intermittent or co-ordinated growth factor secretion Presence of tumor suppressor genes Normal cell Few mitoses Frequent mitoses Nucleus Blood vessel Abnormal heterogeneous cells
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. The Cell Cycle G1/S checkpoint G2/M checkpoint DEATH DIFFERENTIATION DNA content = 2n Mitosis M S DNA synthesis G 2 G 1 G 0 DNA content = 4n
  • 11. CYCLIN, CDK,CDKI: PHOSPHORYLATION
  • 12.
  • 13.
  • 14.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27. ONCOGENE FAMILY Classification of Oncogenes A. Secreted Growth Factors B. Cell Surface Receptors C. Intracellular Transducers D. DNA-binding Nuclear Proteins E. Regulators of the Cell Cycle Components of signal transduction pathways c-sis, hst erb B, fms, ret, trk, fes, fms c-src, c-abl, mst, ras myc, jun, fos bcl, bax, bad
  • 29. ONCOGENE FAMILY Mechanisms of Oncogene Activation 1. Point Mutation H-ras [codon 12] Normal C G C  Gly Bladder ca C T C  Val H-ras GTP Perpetual cell division 2. Gene Amplification Double minutes HSRs Normal copy Multiple copies
  • 30. ONCOGENE FAMILY Mechanisms of Oncogene Activation 3. Gene Translocation Ex. Burkitt’s Lymphoma
  • 31. ONCOGENE FAMILY Mechanisms of Oncogene Activation 3. Gene Translocation Ex. Chronic Myelogenous Leukemia [CML]
  • 32. ONCOGENE FAMILY Mechanisms of Oncogene Activation 4. Viral Gene Integration promoter Viral promoter
  • 33.
  • 34. TUMOR SUPPRESSOR GENE FAMILY KNUDSON’S Two-Hit Hypothesis 1st Hit : TS mutation or Inherited mutation 2nd Hit : gross chromosomal loss
  • 35.
  • 36.
  • 37. TUMOR SUPPRESSOR GENE FAMILY p53 protein
  • 39.
  • 40. In summary ….. ONCOGENES TS GENES MUTATOR GENES
  • 41. Re-cap of Molecular Carcinogenesis Proto-oncogene Gain-of-function TS gene Loss-of-function Mutator gene Loss-of-function CANCER
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49. CARCINOGEN METABOLISM Three Main Categories: I. Chemical Carcinogens II. Physical Carcinogens III. Viral Agents Carcinogens Mutations Cancer Environmental factors ?
  • 50. CHEMICAL CARCINOGENESIS Stages: Initiation - primary exposure Promotion - transformation Progression - Cancer growth Frank Cancer
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56. PHYSICAL CARCINOGENESIS Ultraviolet Rays UV-A = 320 - 400 nm UV-B = 280 - 320 nm UV-C = 200 - 280 nm
  • 57. PHYSICAL CARCINOGENESIS Ultraviolet Rays UV-C  filtered by ozone UV-B Inhibition of cell division inactivation of enzymes induction of mutations cell death at high doses Squamous cell cancer Basal cell cancer Melanocarcinoma
  • 58.
  • 59.
  • 60. Viral Oncogenes RETROVIRUS Oncogene Viral RNA Viral DNA NUCLEUS DNA Oncogene REVERSE TRANSCRIPTASE INSERTION TRANSCRIPTION Oncogene Viral RNA CELL MEMBRANE CYTOPLASM Viral genome RNA messenger TRANSCRIPTION Oncogene protein
  • 61.
  • 62.
  • 63. VIRAL AGENTS: DNA viruses Human Papillomavirus [HPV types 16, 18, 31, 33 & 35] Interruption of the E1/E2 ORF E2 is not expressed Over-expression of E6 & E7
  • 64.
  • 65.
  • 66.
  • 68.
  • 69.
  • 70.
  • 72.
  • 73. The Cell Cycle G1/S checkpoint G2/M checkpoint DEATH DIFFERENTIATION DNA content = 2n Mitosis M S DNA synthesis G 2 G 1 G 0 DNA content = 4n
  • 74.
  • 75.
  • 76.
  • 77. CYCLIN, CDK,CDKI: PHOSPHORYLATION
  • 78.
  • 80.
  • 81.
  • 84.
  • 85.
  • 86.
  • 87.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.
  • 95.
  • 97.
  • 98.
  • 99.
  • 100.
  • 101.
  • 102.
  • 104.
  • 106.
  • 108.
  • 109.
  • 110.
  • 111.

Notas del editor

  1. <number>
  2. <number>
  3. All cancers are similar in that the different diseases will all have these basic characteristics.<number>
  4. It is believed that all tumors arise as clones from a genetically damaged cell. Hence, at the molecular level, cancer is a genetic and a clonal disease.The results of genetic instability are as follows:The resulting cells appear different from the parent cells so that a tumor that arises from the lung may have features similar to normal lung cells but do not act nor function as lung cells or may even look totally different from normal lung cells.The result of genetic instability is the production of abnormal proteins that stimulate cellular proliferation. This results in uncontrolled division and tumor formation.Proto-oncogenes are precursors of oncogenes (inactivated oncogenes). They occur naturally and are normally activated when increased cellular proliferation is required (as in, embryonic development). However, in a normal individual, these proto-oncogenes are normally inactivated or kept in check by suppressor genes.A dominant mutation occurs when an event results in the conversion of a proto-oncogene to an oncogene.A recessive mutation occurs when there is damage or loss of a tumor suppressor gene resulting in an unchecked, and therefore expressed, oncogene.
  5. <number>
  6. A basic characteristic of cancer is its capacity to proliferate outside the normal control mechanisms of the organism. This capacity, as previously seen, arises from damage inflicted on the cell’s genetic apparatus. Uncontrolled growth can be stimulated by either:Secretion of growth factorsIncreased growth factor receptors (making the cell sensitive to normal levels of growth factors).Independent activation of certain enzyme or protein production pathways.To understand the biology of cellular proliferation, one musty be familiar with the cell regeneration cycle.
  7. <number>
  8. <number>
  9. <number>
  10. <number>
  11. <number>
  12. <number>
  13. <number>
  14. <number>
  15. <number>
  16. <number>
  17. <number>
  18. <number>
  19. <number>
  20. <number>
  21. <number>
  22. <number>
  23. <number>
  24. <number>
  25. <number>
  26. This slide lists the different carcinogenic agents identified. By far, chemical carcinogens are the most common. More significant though are lifestyle carcinogens such as the following:Cigarette smokingDiet – high fat, high sodium, low fiber diets have predisposed populations to increase rates of gastrointestinal cancers.Sexual practices – multiple sexual partners can result in the spread of the human papilloma virus (causes cervical cancer), the Hepatitis B virus (causes liver cancer), and the HIV virus (causes AIDS related malignancies)Knowledge of these carcinogens are important because cancer may be prevented if these are avoided. Also, lifestyle related cancers are important to consider because of the role of behavior modification in their avoidance.
  27. <number>
  28. <number>
  29. <number>
  30. <number>
  31. <number>
  32. <number>
  33. 57
  34. 57
  35. <number>
  36. <number>
  37. <number>
  38. <number>
  39. <number>
  40. <number>